Sao Paulo, November 19, 2015 -- Moody's América Latina (Moody's) has withdrawn Brasil Pharma S.A.'s Caa1 (global scale) and B3.br (national scale) corporate family ratings, as well as the negative outlook.
Vollständigen Artikel bei Moodys lesen